Antimüllerian hormone and adiposity across midlife among women in Project Viva
Sign Up to like & getrecommendations! Published in 2023 at "Menopause"
DOI: 10.1097/gme.0000000000002143
Abstract: Low antimüllerian hormone (AMH) at baseline was associated with greater adiposity concurrently and across ~ 9 years of follow-up. Whether low AMH is a useful marker of metabolic risk across mid-life requires further research. Abstract… read more here.
Keywords: years follow; antim llerian; adiposity; llerian hormone ... See more keywords